Dr. Costello, Consultant Gastroenterologist at The Queen Elizabeth Hospital, Adelaide, Australia shares the latest clinical data around microbial based therapies, such as FMT, and how they influence gut health and patient outcomes.
More Projects
Dietary Guidance in IBD: From Pathogenesis to Optimised Nutrition
Prof Arie Levine, Director of Pediatric Gastroenterology and Nutrition Unit, Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
New Imaging Technologies
Prof. Raf Bisschops, Head of Endoscopy, UZ Leuven, Belgium
Calprotectin for Monitoring IBD Patients
Presented by Dr. Johan Burisch, Gastroenterlogist (Hvidovre Hospital, Hvidovre, Denmark)
